Trial Profile
Phase 2 proof of concept clinical trial in patients with cancer cachexia
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 17 Feb 2015
Price :
$35
*
At a glance
- Drugs VK 5211 (Primary)
- Indications Cachexia
- Focus Pharmacodynamics; Proof of concept
- Sponsors Viking Therapeutics
- 17 Feb 2015 New trial record